MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk

12Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

The MDM2 proto-oncogene plays a key role in central cellular processes like growth control and apoptosis, and the gene locus is frequently amplified in sarcomas. Two polymorphisms located in the MDM2 promoter P2 have been shown to affect cancer risk. One of these polymorphisms (SNP309T

Cite

CITATION STYLE

APA

Knappskog, S., Gansmo, L. B., Romundstad, P., Bjørnslett, M., Trovik, J., Sommerfelt-Pettersen, J., … Lønning, P. E. (2012). MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk. PLoS ONE, 7(4). https://doi.org/10.1371/journal.pone.0036263

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free